Loading…
ZIPAMOL is a brand name for Acetaminophen (also known as Paracetamol). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Treatment of mild to moderate pain and/or fever.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults, the elderly and children over 16 years:
One or two tablets to be taken up to four times daily. Maximum dose of 8 tablets in 24 hours.
Children 12-15 years :
One tablet, every 4-6 hours when necessary to a maximum of 4 doses in 24 hours.
Children under 12 years of age:
Not recommended. The dose should not be repeated more frequently than every 4 hours, and not more than 4 doses should be taken in any 24 hour period. Dosage should not be continued for more than 3 days without consulting a doctor. Method of administration For oral administration.
The tablets should be placed in a full glass of water and allowed to dissolve completely before swallowing.
The frequency using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), including isolated reports; not known (cannot be estimated from the available data).
Within each frequency grouping, undesirable effects are presented in order of system organ class. Frequency System Symptoms Blood and lymphatic system disorders Platelet disorders, stem cell disorders. Immune system disorders Allergies (excluding angioedema).
Psychiatric disorders Depression NOS, confusion, hallucinations. Nervous system disorders Tremor NOS, headache NOS. Eye disorders Abnormal vision. Cardiac disorders Oedema. Gastrointestinal disorders Haemorrhage NOS, abdominal pain NOS, diarrhoea NOS, nausea, vomiting.
Hepatobiliary disorders Hepatic function abnormal, hepatic failure, hepatic necrosis, jaundice. Skin and subcutaneous tissue disorders Pruritus, rash, sweating, purpura, angioedema, urticaria. Rare General disorders and administration site conditions Dizziness (excluding vertigo), malaise, pyrexia, sedation, drug interaction NOS.
Injury, poisoning and procedural complications Overdose and poisoning. Blood and lymphatic system disorders Thrombocytopenia, leukopenia, neutropenia, haemolytic anaemia, agranulocytosis. Metabolism and nutrition disorders Hypoglycaemia.
Hepatobiliary disorders Hepatotoxicity. Skin and subcutaneous disorders Serious skin reactions have been reported. Renal and urinary disorders Sterile pyuria (cloudy urine) and renal side effects. Very Rare General disorders and administration site conditions Hypersensitivity reaction (requiring discontinuation of treatment).
Not known:
Edema of the larynx, anaphylactic shock, anaemia, bronchospasm*, liver alteration and hepatitis, renal alteration (severe renal impairment, nephrite interstitial, haematuria, anuresis), gastrointestinal effects, vertigo and high anion gap metabolic acidosis have been reported.
Prolonged or frequent use is discouraged. Patients should be advised not to take other Paracetamol containing products concurrently. Taking multiple daily doses in one administration can severely damage the liver; in such case unconsciousness does not occur.
However, medical assistance should be sought immediately. Prolonged use except under medical supervision may be harmful. In adolescents treated with 60mg/kg daily of Paracetamol, the combination with another antipyretic is not justified except in the case of ineffectiveness.
2). The hazards of overdose are greater in those with non- cirrhotic alcoholic liver disease. Caution should be exercised in cases of chronic alcoholism. The daily dose should not exceed 2 grams in such case. Alcohol should not be used during the treatment with Paracetamol.
Caution is advised in asthmatic patients sensitive to aspirin, because light reaction bronchospasm with paracetamol (cross-reaction) has been reported in less than 5% of the patients tested. g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin.
If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended. The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors.
This medicinal product contains sorbitol. Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product. 92% of the WHO recommended maximum daily intake of sodium. 4% of the WHO recommended maximum daily intake for sodium.
This medicinal product is considered high in sodium. This medicinal product should be taken into account for those on a low salt diet. In the case of high fever, or signs of secondary infection or persistence of symptoms a doctor should be consulted.
1
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Acetaminophen in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
* There have been cases of bronchospasm with paracetamol, but these are more likely in asthmatics sensitive to aspirin or other NSAIDs. 4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
9).